182 related articles for article (PubMed ID: 26219660)
1. Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.
Reant P; Captur G; Mirabel M; Nasis A; M Sado D; Maestrini V; Castelletti S; Manisty C; Herrey AS; Syrris P; Tome-Esteban M; Jenkins S; Elliott PM; McKenna WJ; Moon JC
J Cardiovasc Magn Reson; 2015 Jul; 17(1):64. PubMed ID: 26219660
[TBL] [Abstract][Full Text] [Related]
2. Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy.
Captur G; Lopes LR; Mohun TJ; Patel V; Li C; Bassett P; Finocchiaro G; Ferreira VM; Esteban MT; Muthurangu V; Sherrid MV; Day SM; Canter CE; McKenna WJ; Seidman CE; Bluemke DA; Elliott PM; Ho CY; Moon JC
Circ Cardiovasc Imaging; 2014 Nov; 7(6):863-71. PubMed ID: 25228707
[TBL] [Abstract][Full Text] [Related]
3. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.
Tarkiainen M; Sipola P; Jalanko M; Heliö T; Laine M; Järvinen V; Häyrinen K; Lauerma K; Kuusisto J
J Cardiovasc Magn Reson; 2016 Jun; 18(1):33. PubMed ID: 27259862
[TBL] [Abstract][Full Text] [Related]
5. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
6. Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy.
Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
Cardiovasc Ultrasound; 2019 Oct; 17(1):21. PubMed ID: 31660989
[TBL] [Abstract][Full Text] [Related]
7. CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation.
Tarkiainen M; Sipola P; Jalanko M; Heliö T; Jääskeläinen P; Kivelä K; Laine M; Lauerma K; Kuusisto J
Sci Rep; 2019 Apr; 9(1):5960. PubMed ID: 30976029
[TBL] [Abstract][Full Text] [Related]
8. Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression.
Captur G; Lopes LR; Patel V; Li C; Bassett P; Syrris P; Sado DM; Maestrini V; Mohun TJ; McKenna WJ; Muthurangu V; Elliott PM; Moon JC
Circ Cardiovasc Genet; 2014 Jun; 7(3):241-8. PubMed ID: 24704860
[TBL] [Abstract][Full Text] [Related]
9. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
[TBL] [Abstract][Full Text] [Related]
10. Systolic anterior motion of the anterior mitral valve leaflet begins in subclinical hypertrophic cardiomyopathy.
Seitler S; De Zoysa Anthony S; Obianyo CCC; Syrris P; Patel V; Sado DM; Maestrini V; Castelletti S; Walsh S; O'Brien B; Moon JC; Captur G
Eur Heart J Cardiovasc Imaging; 2023 Dec; 25(1):86-94. PubMed ID: 37523765
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
[TBL] [Abstract][Full Text] [Related]
12. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
[TBL] [Abstract][Full Text] [Related]
13. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
Germans T; Rüssel IK; Götte MJ; Spreeuwenberg MD; Doevendans PA; Pinto YM; van der Geest RJ; van der Velden J; Wilde AA; van Rossum AC
J Cardiovasc Magn Reson; 2010 Mar; 12(1):13. PubMed ID: 20230637
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular myocardial diastolic dysfunction in different kinds of cardiac hypertrophy: analysis by pulsed Doppler tissue imaging.
Galderisi M; Severino S; Caso P; Cicala S; Petrocelli A; De Simone L; Mininni N; de Divitiis O
Ital Heart J; 2001 Dec; 2(12):912-20. PubMed ID: 11838339
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
[TBL] [Abstract][Full Text] [Related]
17. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
Vigneault DM; Yang E; Jensen PJ; Tee MW; Farhad H; Chu L; Noble JA; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Ho CY; Bluemke DA
Radiology; 2019 Mar; 290(3):640-648. PubMed ID: 30561279
[TBL] [Abstract][Full Text] [Related]
18. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.
Sipola P; Magga J; Husso M; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Eur Radiol; 2011 Jul; 21(7):1383-9. PubMed ID: 21274714
[TBL] [Abstract][Full Text] [Related]
19. Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic
Parbhudayal RY; Harms HJ; Michels M; van Rossum AC; Germans T; van der Velden J
J Am Heart Assoc; 2020 Apr; 9(8):e015316. PubMed ID: 32290750
[TBL] [Abstract][Full Text] [Related]
20. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
Lakdawala NK; Thune JJ; Maron BJ; Cirino AL; Havndrup O; Bundgaard H; Christiansen M; Carlsen CM; Dorval JF; Kwong RY; Colan SD; Køber LV; Ho CY
Am J Cardiol; 2011 Dec; 108(11):1606-13. PubMed ID: 21943931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
